- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.58 Å
- Oligo State
- homo-tetramer
- Ligands
- 2 x ZN: ZINC ION(Non-covalent)
- 4 x MG: MAGNESIUM ION(Non-covalent)
MG.2: 4 residues within 4Å:- Chain A: D.131, D.188
- Ligands: MG.3, WA5.18
4 PLIP interactions:2 interactions with chain A, 2 Ligand-Water interactions- Metal complexes: A:D.131, A:D.188, H2O.2, H2O.2
MG.3: 5 residues within 4Å:- Chain A: D.131, E.224, N.227
- Ligands: MG.2, WA5.18
4 PLIP interactions:3 interactions with chain A, 1 Ligand-Water interactions- Metal complexes: A:D.131, A:E.224, A:E.224, H2O.2
MG.20: 4 residues within 4Å:- Chain E: D.131, D.188
- Ligands: MG.21, WA5.36
4 PLIP interactions:2 interactions with chain E, 2 Ligand-Water interactions- Metal complexes: E:D.131, E:D.188, H2O.7, H2O.7
MG.21: 5 residues within 4Å:- Chain E: D.131, E.224, N.227
- Ligands: MG.20, WA5.36
4 PLIP interactions:3 interactions with chain E, 1 Ligand-Water interactions- Metal complexes: E:D.131, E:E.224, E:E.224, H2O.7
- 10 x SO4: SULFATE ION(Non-functional Binders)
SO4.4: 4 residues within 4Å:- Chain A: P.138, S.139, Q.140, K.244
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:Q.140, A:Q.140
SO4.8: 5 residues within 4Å:- Chain A: G.190, A.191
- Chain D: A.17
- Ligands: MES.5, WA5.18
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:A.191
- Water bridges: A:A.192
SO4.9: 4 residues within 4Å:- Chain A: S.335, L.336, R.339
- Chain E: K.231
3 PLIP interactions:1 interactions with chain E, 2 interactions with chain A- Salt bridges: E:K.231, A:R.339
- Hydrogen bonds: A:L.336
SO4.10: 3 residues within 4Å:- Chain A: H.341, K.342, H.360
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:K.342
- Salt bridges: A:H.341, A:K.342, A:H.360
SO4.14: 5 residues within 4Å:- Chain B: K.222, R.225, S.261, P.262, V.263
4 PLIP interactions:4 interactions with chain B- Hydrogen bonds: B:S.261, B:V.263
- Salt bridges: B:K.222, B:R.225
SO4.22: 4 residues within 4Å:- Chain E: P.138, S.139, Q.140, K.244
2 PLIP interactions:2 interactions with chain E- Hydrogen bonds: E:Q.140, E:Q.140
SO4.26: 5 residues within 4Å:- Chain E: G.190, A.191
- Chain H: A.17
- Ligands: MES.23, WA5.36
2 PLIP interactions:2 interactions with chain E- Hydrogen bonds: E:A.191
- Water bridges: E:A.192
SO4.27: 4 residues within 4Å:- Chain A: K.231
- Chain E: S.335, L.336, R.339
3 PLIP interactions:1 interactions with chain A, 2 interactions with chain E- Salt bridges: A:K.231, E:R.339
- Hydrogen bonds: E:L.336
SO4.28: 3 residues within 4Å:- Chain E: H.341, K.342, H.360
4 PLIP interactions:4 interactions with chain E- Hydrogen bonds: E:K.342
- Salt bridges: E:H.341, E:K.342, E:H.360
SO4.32: 5 residues within 4Å:- Chain F: K.222, R.225, S.261, P.262, V.263
4 PLIP interactions:4 interactions with chain F- Hydrogen bonds: F:S.261, F:V.263
- Salt bridges: F:K.222, F:R.225
- 2 x MES: 2-(N-MORPHOLINO)-ETHANESULFONIC ACID(Non-covalent)
MES.5: 7 residues within 4Å:- Chain A: D.188, Q.189, G.190, P.214, Y.215
- Ligands: SO4.8, WA5.18
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:Q.189, A:Y.215, A:Y.215
MES.23: 7 residues within 4Å:- Chain E: D.188, Q.189, G.190, P.214, Y.215
- Ligands: SO4.26, WA5.36
2 PLIP interactions:2 interactions with chain E- Hydrogen bonds: E:Q.189, E:Y.215
- 16 x GOL: GLYCEROL(Non-functional Binders)
GOL.6: 7 residues within 4Å:- Chain A: S.228, R.232, T.235
- Chain D: A.15, C.16
- Chain E: R.337, R.339
Ligand excluded by PLIPGOL.7: 5 residues within 4Å:- Chain A: Q.63, L.82, Y.83
- Chain E: P.280, F.281
Ligand excluded by PLIPGOL.11: 4 residues within 4Å:- Chain A: S.165, T.166, S.167, T.197
Ligand excluded by PLIPGOL.12: 3 residues within 4Å:- Chain A: P.118, D.119
- Chain C: T.3
Ligand excluded by PLIPGOL.13: 5 residues within 4Å:- Chain A: R.117, Y.306, P.308
- Chain C: C.6
- Ligands: GOL.17
Ligand excluded by PLIPGOL.15: 6 residues within 4Å:- Chain A: L.295, Q.299
- Chain B: Y.266, Q.270, G.274, D.276
Ligand excluded by PLIPGOL.16: 6 residues within 4Å:- Chain A: S.178
- Chain B: L.158, P.160, Y.246, P.250, Q.253
Ligand excluded by PLIPGOL.17: 8 residues within 4Å:- Chain A: V.263, Y.306
- Chain C: C.6, A.7, T.8
- Chain D: C.11, A.12
- Ligands: GOL.13
Ligand excluded by PLIPGOL.24: 7 residues within 4Å:- Chain A: R.337, R.339
- Chain E: S.228, R.232, T.235
- Chain H: A.15, C.16
Ligand excluded by PLIPGOL.25: 5 residues within 4Å:- Chain A: P.280, F.281
- Chain E: Q.63, L.82, Y.83
Ligand excluded by PLIPGOL.29: 4 residues within 4Å:- Chain E: S.165, T.166, S.167, T.197
Ligand excluded by PLIPGOL.30: 3 residues within 4Å:- Chain E: P.118, D.119
- Chain G: T.3
Ligand excluded by PLIPGOL.31: 5 residues within 4Å:- Chain E: R.117, Y.306, P.308
- Chain G: C.6
- Ligands: GOL.35
Ligand excluded by PLIPGOL.33: 6 residues within 4Å:- Chain E: L.295, Q.299
- Chain F: Y.266, Q.270, G.274, D.276
Ligand excluded by PLIPGOL.34: 6 residues within 4Å:- Chain E: S.178
- Chain F: L.158, P.160, Y.246, P.250, Q.253
Ligand excluded by PLIPGOL.35: 8 residues within 4Å:- Chain E: V.263, Y.306
- Chain G: C.6, A.7, T.8
- Chain H: C.11, A.12
- Ligands: GOL.31
Ligand excluded by PLIP- 2 x WA5: 4-azanylidene-N-[[2,4-bis(fluoranyl)phenyl]methyl]-1-oxidanyl-2-oxidanylidene-1,8-naphthyridine-3-carboxamide(Non-covalent)
WA5.18: 12 residues within 4Å:- Chain A: D.131, D.188, P.217, Q.218, E.224
- Chain C: G.4
- Chain D: C.16, A.17
- Ligands: MG.2, MG.3, MES.5, SO4.8
5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:P.217, A:P.217
- Water bridges: A:D.131, A:Y.132, A:N.227
WA5.36: 12 residues within 4Å:- Chain E: D.131, D.188, P.217, Q.218, E.224
- Chain G: G.4
- Chain H: C.16, A.17
- Ligands: MG.20, MG.21, MES.23, SO4.26
6 PLIP interactions:6 interactions with chain E- Hydrophobic interactions: E:P.217, E:P.217
- Hydrogen bonds: E:D.188, E:E.224
- Water bridges: E:Y.132, E:N.227
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhao, X.Z. et al., HIV-1 Integrase Strand Transfer Inhibitors with Reduced Susceptibility to Drug Resistant Mutant Integrases. Acs Chem.Biol. (2016)
- Release Date
- 2016-02-17
- Peptides
- PFV INTEGRASE: ABEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BE
AF
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.58 Å
- Oligo State
- homo-tetramer
- Ligands
- 2 x ZN: ZINC ION(Non-covalent)
- 4 x MG: MAGNESIUM ION(Non-covalent)
- 10 x SO4: SULFATE ION(Non-functional Binders)
- 2 x MES: 2-(N-MORPHOLINO)-ETHANESULFONIC ACID(Non-covalent)
- 16 x GOL: GLYCEROL(Non-functional Binders)
- 2 x WA5: 4-azanylidene-N-[[2,4-bis(fluoranyl)phenyl]methyl]-1-oxidanyl-2-oxidanylidene-1,8-naphthyridine-3-carboxamide(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhao, X.Z. et al., HIV-1 Integrase Strand Transfer Inhibitors with Reduced Susceptibility to Drug Resistant Mutant Integrases. Acs Chem.Biol. (2016)
- Release Date
- 2016-02-17
- Peptides
- PFV INTEGRASE: ABEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BE
AF
B